Supplemental Methods:
Human steady-state peripheral blood cells: The LDFs were obtained after leukocyte-depletion of the normal donor blood units, collected during the afternoon sessions on the territory of the Nouvelle Aquitaine region. The cells were extracted the next morning after their transport to the Bordeaux transfusion center.
Ex vivo expansion of LDF-recovered CD34+ cells:
When necessary, thawed cells from several cryotubes were pooled, and the same cell pool was used for tests performed at Day-0 and Day-7.
CD34 + cell detection, immunophenotypical analysis and selection of cell subfractions:
Anti-CD34 (FITC), anti-CD184 clone 12G5 (APC), anti-CD9 (PE), anti-CD11a (PE), anti-CD49d (PE), antiCD49e (PE), anti-CD49f (PE), anti-CD90 (PE), anti-CD45RA individual SRC proliferative capacity was evaluated only taking into consideration the cell dose presenting less than 37% of positive mice. In this way, every positive mouse is supposed to be reconstituted by one only SRC.
ii) Long-term HSCs (LT-HSC).
The bone marrow from both femurs of primary recipients was flushed out in 1 mL of medium (RPMI).
Apart from a 65µL aliquot of cell suspension that was used for cell counting and detection of human CD45 + cells by flow cytometry, the total cellular content from both femurs of each primary recipient was centrifuged, resuspended in 20 µL of RPMI medium, DNase 10% (2500 U/mL, Pulmozyme®, Roche, Boulogne-Billancourt, France), and injected intra-femorally (ref 6 and 25, main text) to the secondary recipient NSG mice (Figure 1 , main text). The mice were sacrificed 7-8 weeks later and the same analyses as the ones for primary recipients were performed on the bone marrow cells of injected femurs. To detect LT-HSCs before expansion, 2 x 10 5 Day-0 cells were injected per mouse; to obtain the same information after expansion, 1.6 x 10
Supplemental Table 1   Table S1 . Fold expansion of CXCR4 expressing cells among CD34 -and CD34 + SS-PB cells after Day-7 culture expansion. FITC-anti-CD34 and APC-anti-CXCR4 antibodies were used for SS-PB cell labelling and analysis. All values are mean ± SD after cell sorting for Day-0, and Day-7 cells (15 and 12 samples, respectively).
Supplemental Table 2   Table S2 . Number and proportion of "positive" mice with respect to the CD34 + CD133 + CXCR4 low cell dose injected per one mouse and the mean human CD45 chimerism per cell dose before and after ex vivo expansion. 
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